Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bicyclic antagonists selective for the &agr;v&bgr;3 integrin

Bicyclic antagonists selective for the &agr;v&bgr;3 integrin

US Patent 6429214 · Granted Aug 6, 2002

Estimated economic value: $514,814,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

NT5C2 inhibitors for the treatment of chemotherapy-resistant acute lymphoblastic2025
Substituted pyrrolo[2,3-b]pyridines for suppressing toxic endoplasmic reticulum 2025
Digital messaging system2020
Triazine compounds as PI3 kinase and mTOR inhibitors2018
Pyridopyrimidine or pyrimidopyrimidine compound, prepration method, pharmaceutic2017
Triazine compounds as PI3 kinase and MTOR inhibitors2015
Triazine compounds as PI3 kinase and mTOR inhibitors2014
Pyrimidine compounds, their use as mTOR kinase and Pl3 kinase inhibitors, and th2014
Triazine compounds as P13 kinase and MTOR inhibitors2014
Triazine compounds as PI3 kinase and mTOR inhibitors2013
Triazine compounds as PI3 kinase and mTOR inhibitors2013
Triazine compounds as PI3 kinase and mTOR inhibitors2012